Atlas Venture Life Science Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.8M | Hold |
|
|||||
|
2025
Q1 | $51M | Hold |
|
|||||
|
2024
Q4 | $81.5M | Hold |
|
|||||
|
2024
Q3 | $89.6M | Hold |
|
|||||
|
2024
Q2 | $88.6M | Hold |
|
|||||
|
2024
Q1 | $106M | Sell |
|
|||||
|
2023
Q4 | $111M | Hold |
|
|||||
|
2023
Q3 | $93.4M | Hold |
|
|||||
|
2023
Q2 | $90.8M | Hold |
|
|||||
|
2023
Q1 | $102M | Buy |
|
|||||
|
2022
Q4 | $163M | Sell |
|
|||||
|
2022
Q3 | $164M | Sell |
|
|||||
|
2022
Q2 | $161M | Buy |
|
|||||
|
2022
Q1 | $81.4M | Hold |
|
|||||
|
2021
Q4 | $138M | Buy |
|